🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › Ohio › Columbus

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Columbus, OH keessatti

Qorannoo 9 Diffuse Large B-Cell Lymphoma f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06649812

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • The Ohio State University (OSU), Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06536049

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • The Ohio State University Wexner Medical Center James Cancer, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • The Ohio state University, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05077527

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Namoota walitti qabaa jiraSadarkaa 1
  • Ohio State University, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT04775745

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2025 · NCT05780034

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2022 · NCT04502394

Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti

Qorannoo biroo Columbus keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.